Aleafia Health Inc (AH.CA) Stock Price, Forecast & Analysis

TSX:AH • CA01444Q1046

0.02 CAD
0 (0%)
Last: Jul 25, 2023, 07:00 PM

AH.CA Key Statistics, Chart & Performance

Key Statistics
Market Cap8.06M
Revenue(TTM)54.88M
Net Income(TTM)-39.08M
Shares402.94M
Float396.73M
52 Week High0.09
52 Week Low0.02
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.1
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPO2011-07-29
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
AH.CA short term performance overview.The bars show the price performance of AH.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60

AH.CA long term performance overview.The bars show the price performance of AH.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of AH.CA is 0.02 CAD. In the past month the price decreased by -20%. In the past year, price decreased by -71.43%.

Aleafia Health Inc / AH Daily stock chart

AH.CA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
AH.CA Full Technical Analysis Report

AH.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to AH.CA. AH.CA has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
AH.CA Full Fundamental Analysis Report

AH.CA Financial Highlights

Over the last trailing twelve months AH.CA reported a non-GAAP Earnings per Share(EPS) of -0.1. The EPS increased by 79.4% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%-138.84%
Sales Q2Q%33.46%
EPS 1Y (TTM)79.4%
Revenue 1Y (TTM)52.19%
AH.CA financials

AH.CA Forecast & Estimates

8 analysts have analysed AH.CA and the average price target is 0.15 CAD. This implies a price increase of 665% is expected in the next year compared to the current price of 0.02.

For the next year, analysts expect an EPS growth of 40% and a revenue growth 51.58% for AH.CA


Analysts
Analysts40
Price Target0.15 (650%)
EPS Next Y40%
Revenue Next Year51.58%
AH.CA Analyst EstimatesAH.CA Analyst Ratings

AH.CA Ownership

Ownership
Inst Owners2.06%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
AH.CA Ownership

AH.CA Competitors/Peers

The largest stocks on the Canadian markets in the "Pharmaceuticals" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
BHC BAUSCH HEALTH COS INC1.393.019B
CRON CRONOS GROUP INC36.991.372B
TLRY TILRAY BRANDS INC N/A1.213B
DHT-UN DRI HEALTHCARE TRUST7.31923.524M
DHT-U DRI HEALTHCARE TRUST5.43686.119M
GUD KNIGHT THERAPEUTICS INC132.15625.948M
WEED CANOPY GROWTH CORP N/A597.979M
NGEN NERVGEN PHARMA CORP N/A458.223M
CPH CIPHER PHARMACEUTICALS INC28.02381.475M
TSND TERRASCEND CORP N/A304.466M

About AH.CA

Company Profile

AH logo image Aleafia Health, Inc. engages in the provision of healthcare services, which focuses on medical cannabis healthcare solutions. The company is headquartered in Concord, Ontario and currently employs 158 full-time employees. The company went IPO on 2011-07-29. The firm offers cannabis products in Canada and destined for international markets, including Australia and Germany. The firm operates a virtual medical cannabis clinic staffed by physicians and nurse practitioners, which provide health and wellness services across Canada. The company owns three licensed cannabis production facilities and operates a located distribution center all in the province of Ontario, including an outdoor cannabis cultivation facility in Canada. The firm produces a diverse portfolio of cannabis and cannabis derivative products, including dried flower, pre-roll, milled, vapes, oils, capsules, edibles, sublingual strips, and topicals, for sale in Canada in the medical and adult-use markets, and in select international jurisdictions. Its subsidiaries include Aleafia Inc., Canabo Medical Corporation, Aleafia Farms Inc., Emblem Corp., Emblem Cannabis Corporation, GrowWise Health Limited and other.

Company Info

Aleafia Health Inc

85 Basaltic Road

Concord ONTARIO L4K 1G4 CA

CEO: Geoffrey M. Benic

Employees: 158

AH Company Website

Phone: 19024054600.0

Aleafia Health Inc / AH.CA FAQ

What does Aleafia Health Inc do?

Aleafia Health, Inc. engages in the provision of healthcare services, which focuses on medical cannabis healthcare solutions. The company is headquartered in Concord, Ontario and currently employs 158 full-time employees. The company went IPO on 2011-07-29. The firm offers cannabis products in Canada and destined for international markets, including Australia and Germany. The firm operates a virtual medical cannabis clinic staffed by physicians and nurse practitioners, which provide health and wellness services across Canada. The company owns three licensed cannabis production facilities and operates a located distribution center all in the province of Ontario, including an outdoor cannabis cultivation facility in Canada. The firm produces a diverse portfolio of cannabis and cannabis derivative products, including dried flower, pre-roll, milled, vapes, oils, capsules, edibles, sublingual strips, and topicals, for sale in Canada in the medical and adult-use markets, and in select international jurisdictions. Its subsidiaries include Aleafia Inc., Canabo Medical Corporation, Aleafia Farms Inc., Emblem Corp., Emblem Cannabis Corporation, GrowWise Health Limited and other.


What is the current price of AH stock?

The current stock price of AH.CA is 0.02 CAD.


Does Aleafia Health Inc pay dividends?

AH.CA does not pay a dividend.


How is the ChartMill rating for Aleafia Health Inc?

AH.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


What sector and industry does Aleafia Health Inc belong to?

Aleafia Health Inc (AH.CA) operates in the Health Care sector and the Pharmaceuticals industry.


Can you provide the growth outlook for Aleafia Health Inc?

The Revenue of Aleafia Health Inc (AH.CA) is expected to grow by 51.58% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.